Table 2 Univariate survival analysis of patient/tumour characteristics
From: The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer
Variable | Total Number (%) | Mean DSS (months) | 95% CI (months) | log rank p value |
|---|---|---|---|---|
Gender | Â | Â | Â | Â |
Male | 266 (57) | 64 | 57–70 |  |
Female | 196 (42) | 64 | 57–71 | 0.8374 |
Age (years) | Â | Â | Â | Â |
<64 | 71 (15) | 66 | 54–77 |  |
65–79 | 316 (68) | 64 | 58–69 |  |
80+ | 75 (16) | 61 | 49–72 | 0.9602 |
Tumour Grade | Â | Â | Â | Â |
Well | 29 (6) | 66 | 45–86 |  |
Moderate | 353 (76) | 65 | 60–71 |  |
Poor | 71 (15) | 57 | 46–69 |  |
Unknown | 9 (2) | 52 | 7–37 | 0.0627 |
Tumour Site | Â | Â | Â | Â |
Colon | 238 (52) | 66 | 59–72 |  |
Rectum | 181 (39) | 65 | 58–73 |  |
Unknown | 43 (9) | 46 | 31–60 | 0.0620 |
TNM Stage | Â | Â | Â | Â |
0/I | 72 (15) | 98 | 89–106 |  |
II | 174 (38) | 79 | 71–86 |  |
III | 155 (33) | 52 | 44–59 |  |
IV | 54 (12) | 8 | 6–10 |  |
Unknown | 7 (2) | 29 | 8–50 | <0.0001 |
Vascular Invasion Status | Â | Â | Â | Â |
Absent | 224 (48) | 75 | 68–81 |  |
Present | 128 (28) | 38 | 31–45 |  |
Unknown | 110 (24) | 68 | 59–78 | <0.0001 |
Tumour type | Â | Â | Â | Â |
Adenocarcinoma | 392 (84) | 65 | 60–70 |  |
Mucinous | 51 (11) | 66 | 52–79 |  |
Columnar | 4 (1) | 51 | 8–94 |  |
Signet ring | 7 (2) | 27 | 11–44 | 0.4860 |
MUC1 expression | Â | Â | Â | Â |
High | 127 (32) | 54 | 45–62 |  |
Low | 276 (68) | 65 | 60–71 | 0.038 |
MUC3 expression | Â | Â | Â | Â |
High | 286 (74) | 63 | 57–69 |  |
Low | 101 (26) | 59 | 49–69 | 0.552 |